FDA inspection
Strive Pharmaceuticals, Inc.: FDA inspection ending Mar 5, 2025
FDA inspection 1263613 · No Action Indicated (NAI) · East Brunswick, NJ
Key facts
| Inspection ID | 1263613 |
|---|---|
| Firm | Strive Pharmaceuticals, Inc. |
| FEI number | 3013896178 |
| Address | 19 Lexington Ave |
| City | East Brunswick |
| State | NJ |
| ZIP | 08816 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Mar 5, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Food Composition, Standards, Labeling and Econ |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data